Natural Product: NPC527452

Natural Product IDNPC527452
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(8~{S},9~{S},10~{R},13~{S},14~{S},17~{R})-10,13-dimethyl-17-[(1~{S})-1-methyl-2-oxo-propyl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
IUPAC Name (8~{S},9~{S},10~{R},13~{S},14~{S},17~{R})-10,13-dimethyl-17-[(1~{S})-1-methyl-2-oxo-propyl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey MUQIYHIBKQKOOI-KZJFZMNRSA-N
Standard InCHI InChI=1S/C23H34O2/c1-14(15(2)24)19-7-8-20-18-6-5-16-13-17(25)9-11-22(16,3)21(18)10-12-23(19,20)4/h13-14,18-21H,5-12H2,1-4H3/t14-,18+,19-,20+,21+,22+,23-/m1/s1
SMILES CC(=O)[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   342.26 Volume:   381.809
?
Van der Waals volume.
Dense:   0.896 LogP:   3.64
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.318
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.0
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   2.0 Rigid Bonds:   22.0
TPSA:   34.14
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   0.0 Rings:   4.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.677 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.195 Fsp3:   0.826
MCE-18:   69.333
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.398 Fluc inhibitor:   0.003
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.021
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.0
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.636 Promiscuous compounds:   0.896

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.688 MDCK Permeability:   -4.842
Pgp-inhibitor:   0.807 Pgp-substrate:   0.001
PAMPA:   0.002
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.019 30% Bioavailability (F30%):   0.072
50% Bioavailability (F50%):   0.542

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.244 MRP1:   0.185
Plasma Protein Binding (PPB):   96.738% Volume Distribution (VD):   0.112
Fu: 3.835%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.612
BSEP inhibitor:   0.998

ADMET: Metabolism

CYP1A2-inhibitor:   0.001 CYP1A2-substrate:   0.978
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.008
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.487
CYP2D6-inhibitor:   0.208 CYP2D6-substrate:   0.201
CYP3A4-inhibitor:   1.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.836
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  14.114 Half-life (T1/2):  0.543

ADMET: Toxicity

hERG Blockers:  0.204 hERG Blockers (10um):  0.41
Human Hepatotoxicity (H-HT):  0.716 Drug-induced Liver Injury (DILI):  0.494
AMES Toxicity:  0.227 Rat Oral Acute Toxicity:  0.09
Maximum Recommended Daily Dose:  0.59 Skin Sensitization:  0.868
Carcinogencity:  0.94 Eye Corrosion:  0.261
Eye Irritation:  0.973 Respiratory Toxicity:  0.792
Drug-induced Neurotoxicity:  0.191 Ototoxicity:  0.41
Hematotoxicity:  0.838 Drug-induced Nephrotoxicity:  0.552
Genotoxicity:  0.665 RPMI-8226 Immunitoxicity:  0.034
A549 Cytotoxicity:  0.059 Hek293 Cytotoxicity:  0.588
BCF:   1.003
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.604
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.102
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.541
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21744 Aldisa smaragdina Species Dorididae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO21744 Aldisa smaragdina Species Dorididae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC527452 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.8182 Intermediate Similarity NPC307176
0.8182 Intermediate Similarity NPC321874
0.7917 Intermediate Similarity NPC249312
0.7872 Intermediate Similarity NPC35734
0.766 Intermediate Similarity NPC282593
0.75 Intermediate Similarity NPC159577
0.75 Intermediate Similarity NPC115023
0.75 Intermediate Similarity NPC602429
0.7347 Intermediate Similarity NPC149203
0.7292 Intermediate Similarity NPC214043
0.7292 Intermediate Similarity NPC85774
0.7 Intermediate Similarity NPC237712
0.6545 Remote Similarity NPC320514
0.6458 Remote Similarity NPC139397
0.62 Remote Similarity NPC2634
0.62 Remote Similarity NPC265782
0.62 Remote Similarity NPC251929
0.5962 Remote Similarity NPC227064
0.5962 Remote Similarity NPC329043
0.5962 Remote Similarity NPC58841
0.5962 Remote Similarity NPC161423
0.5926 Remote Similarity NPC323765
0.5849 Remote Similarity NPC144258
0.5849 Remote Similarity NPC327115
0.5741 Remote Similarity NPC328539
0.5714 Remote Similarity NPC469948
0.5636 Remote Similarity NPC303613
0.5536 Remote Similarity NPC310010
0.5536 Remote Similarity NPC326627
0.5484 Remote Similarity NPC187159
0.5333 Remote Similarity NPC305039
0.5333 Remote Similarity NPC205860
0.5254 Remote Similarity NPC309603
0.5172 Remote Similarity NPC185936
0.5172 Remote Similarity NPC168027
0.5094 Remote Similarity NPC92327
0.5091 Remote Similarity NPC255021
0.5091 Remote Similarity NPC474228

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC527452 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8182 Intermediate Similarity NPD4747 Phase 4
0.6604 Remote Similarity NPD5737 Phase 4
0.6364 Remote Similarity NPD6672 Phase 4
0.62 Remote Similarity NPD4691 Approved
0.5962 Remote Similarity NPD3666 Phase 4
0.5962 Remote Similarity NPD4221 Phase 4
0.5893 Remote Similarity NPD6409 Approved
0.5818 Remote Similarity NPD5330 Phase 4
0.5818 Remote Similarity NPD6938 Clinical (unspecified phase)
0.5818 Remote Similarity NPD6939 Phase 3
0.5636 Remote Similarity NPD4693 Phase 3
0.5536 Remote Similarity NPD4753 Phase 2
0.5333 Remote Similarity NPD6083 Phase 4
0.5333 Remote Similarity NPD6084 Phase 2
0.5333 Remote Similarity NPD6684 Phase 4
0.5333 Remote Similarity NPD6904 Phase 4
0.5333 Remote Similarity NPD7334 Approved
0.5333 Remote Similarity NPD7521 Phase 4
0.5246 Remote Similarity NPD6903 Phase 4
0.5079 Remote Similarity NPD7513 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data